Table 6 Candidate features have different expression level between GBM and LGG
TCGA | GSE16011 | GSE4271 | GSE4412 | |||||
|---|---|---|---|---|---|---|---|---|
GBM | LGG | GBM | LGG | GBM | LGG | GBM | LGG | |
CTSZ/IPO8 | + (79.22%) | - (65.12%) | + (62.71%) | - (80.77%) | ||||
EFEMP2/IPO8 | + (78.57%) | - (89.15%) | + (83.02%) | - (64.22%) | ||||
EFEMP2/SDHA | + (58.44%) | - (96.12%) | + (52.83%) | - (85.32%) | + (61.84%) | - (83.33%) | ||
EFEMP2/TBP | + (94.16%) | - (50.39%) | + (81.76%) | - (64.22%) | + (79.66%) | - (65.38%) | ||
ITGA3/IPO8 | + (52.60%) | - (88.37%) | + (62.71%) | - (92.31%) | ||||
ITGA5/IPO8 | + (56.49%) | - (95.54%) | + (60.38%) | - (79.82%) | ||||
KDELR2/SDHA | + (98.70%) | - (70.74%) | + (83.02%) | - (64.22%) | ||||
LITAF/SDHA | + (80.52%) | - (79.46%) | + (88.68%) | - (54.13%) | ||||
MAP 2 K3/TBP | + (90.26%) | - (63.37%) | + (69.49%) | - (61.54%) | ||||
MDK/IPO8 | + (85.06%) | - (87.02%) | + (76.73%) | - (74.31%) | + (79.66%) | - (73.08%) | ||
MICALL2/TBP | + (83.77%) | - (53.10%) | + (81.76%) | - (55.96%) | ||||
NRP1/IPO8 | + (57.79%) | - (92.83%) | + (57.86%) | - (73.39%) | + (86.84%) | - (70.83%) | ||
P4HA2/TBP | + (57.79%) | - (85.27%) | + (62.89%) | - (86.24%) | ||||
PDIA4/SDHA | + (94.81%) | - (75.78%) | + (78.95%) | - (70.83%) | ||||
PLAUR/TBP | + (71.43%) | - (89.73%) | + (67.80%) | - (92.31%) | ||||
PLOD3/SDHA | + (50.09%) | - (92.25%) | + (84.91%) | - (55.96%) | ||||
SERPINE1/IPO8 | + (68.18%) | - (88.76%) | + (67.30%) | - (77.98%) | + (76.32%) | - (70.83%) | + (84.75%) | - (65.38%) |
SERPINE1/TBP | + (96.10%) | - (60.08%) | + (69.18%) | - (79.82%) | ||||
SOCS3/IPO8 | + (50.65%) | - (92.64%) | + (74.58%) | - (69.23%) | ||||